"watch this before it disappears" is common to iffy miracle cures. Here's what the AARP says:

AARP does not back or endorse a single specific treatment for Alzheimer's disease. Instead, informational resources published by the organization outline all FDA-approved medical options—such as disease-modifying monoclonal antibodies like Leqembi and Kisunla, as well as symptom-managing drugs like cholinesterase inhibitors—while emphasizing that choices must be personalized with a doctor.

Treatment Overviews Reported by AARP
Disease-Modifying Drugs: Highlights medications like Leqembi (lecanemab) and Kisunla (donanemab) that target amyloid plaques for early-stage patients, alongside their potential risks.

Symptom Management: Mentions traditional options like Aricept (donepezil) and Namenda (memantine) used to manage cognition or behavioral changes.

Caution Against Cures: Warns members to be wary of unverified supplements or alternative products promising a quick fix or magic pill.